Skip to main content
. 2015 Mar 17;29(2):115–120. doi: 10.3341/kjo.2015.29.2.115

Fig. 2. Botulinum neurotoxin type A injection sites in the conventional injection group and the individualized injection group in blepharospasm patients. (A) Coventional injection sites of botulinum neurotoxin type A in essential blepharospasm and (B) spasm-dominant sites in essential blepharospasm.

Fig. 2